Track the Metagenomi Therapeutics, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €45.6m. The latest transaction was filed on 10 September 2026 (Cession). Among the most active insiders: Irish Jian. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€7,227
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Metagenomi Therapeutics, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$7.67.
39Σ signal
Buys n/a€7,227 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.